467 related articles for article (PubMed ID: 15287094)
1. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation.
Wang W; Bergh A; Damber JE
Prostate; 2007 Aug; 67(11):1238-46. PubMed ID: 17570496
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis.
Aoki T; Tsukinoki K; Karakida K; Ota Y; Otsuru M; Kaneko A
Oral Oncol; 2004 Oct; 40(9):954-9. PubMed ID: 15380175
[TBL] [Abstract][Full Text] [Related]
5. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate.
Badawi AF; Liu Y; Eldeen MB; Morrow W; Razak ZR; Maradeo M; Badr MZ
Carcinogenesis; 2004 Sep; 25(9):1681-8. PubMed ID: 15117812
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.
Subbarayan V; Sabichi AL; Llansa N; Lippman SM; Menter DG
Cancer Res; 2001 Mar; 61(6):2720-6. PubMed ID: 11289153
[TBL] [Abstract][Full Text] [Related]
7. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
Wang W; Bergh A; Damber JE
APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
König JE; Senge T; Allhoff EP; König W
Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-2 in prostate carcinoma.
Yoshimura R; Sano H; Masuda C; Kawamura M; Tsubouchi Y; Chargui J; Yoshimura N; Hla T; Wada S
Cancer; 2000 Aug; 89(3):589-96. PubMed ID: 10931458
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer.
Wang W; Bergh A; Damber JE
Clin Cancer Res; 2005 May; 11(9):3250-6. PubMed ID: 15867220
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells.
Munkarah AR; Morris R; Baumann P; Deppe G; Malone J; Diamond MP; Saed GM
J Soc Gynecol Investig; 2002; 9(3):168-73. PubMed ID: 12009392
[TBL] [Abstract][Full Text] [Related]
13. [Cell apoptosis and proliferation in the transition and peripheral zones in human prostate].
Sun HB; Xia SJ
Zhonghua Nan Ke Xue; 2007 Feb; 13(2):110-3. PubMed ID: 17345763
[TBL] [Abstract][Full Text] [Related]
14. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
Wang W; Bergh A; Damber JE
Prostate; 2009 Sep; 69(13):1378-86. PubMed ID: 19507201
[TBL] [Abstract][Full Text] [Related]
15. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 and Bcl-2 expression in the stomach mucosa of Wistar rats exposed to Helicobacter pylori, N'-methyl- N'-nitro- N-nitrosoguanidine and bile.
Loogna P; Franzén L; Sipponen P; Domellöf L
Virchows Arch; 2002 Jul; 441(1):77-84. PubMed ID: 12111204
[TBL] [Abstract][Full Text] [Related]
18. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
Zang T; Sun F; Li Y
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
[TBL] [Abstract][Full Text] [Related]
19. Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation.
Cardillo M; Berchem G; Tarkington MA; Krajewski S; Krajewski M; Reed JC; Tehan T; Ortega L; Lage J; Gelmann EP
J Urol; 1997 Jul; 158(1):212-6. PubMed ID: 9186362
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression.
Tanji N; Kikugawa T; Yokoyama M
Anticancer Res; 2000; 20(4):2313-9. PubMed ID: 10953290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
